Literature DB >> 18182317

Requirements for PKC-augmented JNK activation by MKK4/7.

Pablo Lopez-Bergami1, Ze'ev Ronai.   

Abstract

The c-Jun N-terminal kinases (JNKs) are activated in response to stress, DNA damage, and cytokines by MKK4 and MKK7. We recently demonstrated that PKC can augment the degree of JNK activation by phosphorylating JNK, which requires the adaptor protein RACK1. Here we report on the conditions required for PKC-dependent JNK activation. In vitro kinase assays reveal that PKC phosphorylation of JNK is not sufficient for its activation but rather augments JNK activation by canonical JNK upstream kinases MKK4 or MKK7 alone or in combination. Further, to enhance JNK activity, PKC phosphorylation of JNK should precede its phosphorylation by MKK4/7. Inhibition of PKC phosphorylation of JNK affects both early and late phases of JNK activation following UV-irradiation and reduces the apoptotic response mediated by JNK. These data provide important insight into the requirements for PKC activation of JNK signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18182317      PMCID: PMC2327215          DOI: 10.1016/j.biocel.2007.11.011

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  37 in total

1.  The JIP family of MAPK scaffold proteins.

Authors:  A J Whitmarsh
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

2.  NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta.

Authors:  Jing Liu; Dan Yang; Yuzuru Minemoto; Michael Leitges; Marsha R Rosner; Anning Lin
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

3.  c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.

Authors:  Christina Nielsen; Jacob Thastrup; Trine Bøttzauw; Marja Jäättelä; Tuula Kallunki
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

4.  c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.

Authors:  Jian Cui; Shuang-Yin Han; Congli Wang; Wanwen Su; Larry Harshyne; Marina Holgado-Madruga; Albert J Wong
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

5.  c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.

Authors:  T S Khatlani; M Wislez; M Sun; H Srinivas; K Iwanaga; L Ma; A E Hanna; D Liu; L Girard; Y H Kim; J R Pollack; J D Minna; I I Wistuba; J M Kurie
Journal:  Oncogene       Date:  2006-10-23       Impact factor: 9.867

6.  Rewired ERK-JNK signaling pathways in melanoma.

Authors:  Pablo Lopez-Bergami; Conway Huang; James S Goydos; Dana Yip; Menashe Bar-Eli; Meenhard Herlyn; Keiran S M Smalley; Alka Mahale; Alexey Eroshkin; Stuart Aaronson; Ze'ev Ronai
Journal:  Cancer Cell       Date:  2007-05       Impact factor: 31.743

7.  c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression.

Authors:  Chang Tong; Zhinan Yin; Zibo Song; Ashley Dockendorff; Chuanshu Huang; John Mariadason; Richard A Flavell; Roger J Davis; Leonard H Augenlicht; Wancai Yang
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  Autophosphorylation properties of inactive and active JNK2.

Authors:  Genaro Pimienta; Scott B Ficarro; Gustavo J Gutierrez; Anindita Bhoumik; Eric C Peters; Ze'ev Ronai; Jaime Pascual
Journal:  Cell Cycle       Date:  2007-05-10       Impact factor: 4.534

9.  JNK2 is a positive regulator of the cJun transcription factor.

Authors:  Anja Jaeschke; Maria Karasarides; Juan-Jose Ventura; Anka Ehrhardt; Chao Zhang; Richard A Flavell; Kevan M Shokat; Roger J Davis
Journal:  Mol Cell       Date:  2006-09-15       Impact factor: 17.970

10.  Chemical genetic analysis of the time course of signal transduction by JNK.

Authors:  Juan-Jose Ventura; Anette Hübner; Chao Zhang; Richard A Flavell; Kevan M Shokat; Roger J Davis
Journal:  Mol Cell       Date:  2006-03-03       Impact factor: 17.970

View more
  16 in total

1.  Vibrio cholerae Cholix Toxin-Induced HepG2 Cell Death is Enhanced by Tumor Necrosis Factor-Alpha Through ROS and Intracellular Signal-Regulated Kinases.

Authors:  Kohei Ogura; Yasuhiro Terasaki; Tohru Miyoshi-Akiyama; Mika Terasaki; Joel Moss; Masatoshi Noda; Kinnosuke Yahiro
Journal:  Toxicol Sci       Date:  2017-04-01       Impact factor: 4.849

2.  Inhibition of TROY promotes OPC differentiation and increases therapeutic efficacy of OPC graft for spinal cord injury.

Authors:  Liang Sun; Shengliang Liu; Qi Sun; Zhuying Li; Fengyan Xu; Chunmei Hou; Toshihide Harada; Ming Chu; Kun Xu; Xiaoling Feng; Yongshun Duan; Yafang Zhang; Shuliang Wu
Journal:  Stem Cells Dev       Date:  2014-06-16       Impact factor: 3.272

3.  BPGAP1 spatially integrates JNK/ERK signaling crosstalk in oncogenesis.

Authors:  T Jiang; C Q Pan; B C Low
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

4.  Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage.

Authors:  Da-Zhi Liu; Frank R Sharp
Journal:  Transl Stroke Res       Date:  2012-03-15       Impact factor: 6.829

Review 5.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

6.  Degradation of newly synthesized polypeptides by ribosome-associated RACK1/c-Jun N-terminal kinase/eukaryotic elongation factor 1A2 complex.

Authors:  Valentina Gandin; Gustavo J Gutierrez; Laurence M Brill; Tal Varsano; Yongmei Feng; Pedro Aza-Blanc; Qingyan Au; Shannon McLaughlan; Tiago A Ferreira; Tommy Alain; Nahum Sonenberg; Ivan Topisirovic; Ze'ev A Ronai
Journal:  Mol Cell Biol       Date:  2013-04-22       Impact factor: 4.272

Review 7.  RACK1 Function in Cell Motility and Protein Synthesis.

Authors:  Valentina Gandin; Daniela Senft; Ivan Topisirovic; Ze'ev A Ronai
Journal:  Genes Cancer       Date:  2013-09

8.  FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress.

Authors:  Sandra Pereira; Edward Park; Yusaku Mori; C Andrew Haber; Ping Han; Toyoyoshi Uchida; Laura Stavar; Andrei I Oprescu; Khajag Koulajian; Alexander Ivovic; Zhiwen Yu; Deling Li; Thomas A Bowman; Jay Dewald; Jamel El-Benna; David N Brindley; Roger Gutierrez-Juarez; Tony K T Lam; Sonia M Najjar; Robert A McKay; Sanjay Bhanot; I George Fantus; Adria Giacca
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-13       Impact factor: 4.310

9.  c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis.

Authors:  Pablo Lopez-Bergami; Hyungsoo Kim; Antimone Dewing; James Goydos; Stuart Aaronson; Ze'ev Ronai
Journal:  J Biol Chem       Date:  2009-11-12       Impact factor: 5.157

10.  IL-33 attenuates anoxia/reoxygenation-induced cardiomyocyte apoptosis by inhibition of PKCβ/JNK pathway.

Authors:  Tao Rui; Qizhu Tang
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.